These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20270694)

  • 1. Clotting defect in hemophilia; deficiency in a plasma factor required for platelet utilization.
    BRINKHOUS KM
    Proc Soc Exp Biol Med; 1947 Oct; 66(1):117-20. PubMed ID: 20270694
    [No Abstract]   [Full Text] [Related]  

  • 2. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets.
    BRINKHOUS KM
    Fed Proc; 1947; 6(1):389. PubMed ID: 20343817
    [No Abstract]   [Full Text] [Related]  

  • 3. [SHORT SURVEY ON RESEARCH LEADING TO A CLARIFICATION OF HEMOPHILIA].
    KUKOWKA A
    Z Gesamte Inn Med; 1963 Aug; 18():730-8. PubMed ID: 14083669
    [No Abstract]   [Full Text] [Related]  

  • 4. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.
    HARDISTY RM; HUTTON RA
    Br J Haematol; 1965 May; 11():258-68. PubMed ID: 14282063
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombokinase formation and the reaction of thrombocyte factor 1 in hypoproacelerinemia (parahemophilia); preliminary report].
    DEUTSCH E
    Wien Z Inn Med; 1955 Aug; 36(8):355-7. PubMed ID: 13282274
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt.
    Abdelrazik N; Rashad H; Selim T; Tharwat L
    Hematology; 2007 Aug; 12(4):309-14. PubMed ID: 17654057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis.
    BORCHGREVINK CF; OWREN PA
    Acta Med Scand; 1961 Sep; 170():375-83. PubMed ID: 13871204
    [No Abstract]   [Full Text] [Related]  

  • 8. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
    Duan X; Tang M; Zhang J; Yu H; Xu R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS.
    HOAK JC; CONNOR WE; WARNER ED
    J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of the coagulation defect in hemophilia; studies on platelet-free plasmas.
    HARTMAN RC; CONLEY CL; LALLEY JS
    Am J Med; 1949 Apr; 6(4):507. PubMed ID: 18208241
    [No Abstract]   [Full Text] [Related]  

  • 12. New developments in the treatment of pediatric hemophilia and bleeding disorders.
    Branchford BR; Monahan PE; Di Paola J
    Curr Opin Pediatr; 2013 Feb; 25(1):23-30. PubMed ID: 23274430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and utilization of treatment in patients with hemophilia.
    Rocha P; Carvalho M; Lopes M; Araújo F
    BMC Health Serv Res; 2015 Oct; 15():484. PubMed ID: 26502954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet factors related to blood clotting.
    JOHNSON SA; SEEGERS WH
    Bibl Haematol; 1958; 7():346-9. PubMed ID: 13499293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research Progress on Genetic Factors and Hemophilia A Clotting Factor Inhibitor-Review].
    Hu ZB; Sun X; He LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):957-960. PubMed ID: 28641667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited bleeding disorders.
    Blanchette VS; Sparling C; Turner C
    Baillieres Clin Haematol; 1991 Apr; 4(2):291-332. PubMed ID: 1912663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current clotting concepts in urology.
    Kursh ED; Ratnoff OD; Persky L
    J Urol; 1976 Aug; 116(2):214-7. PubMed ID: 950707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine hemophilia; observations on the course, the clotting anomaly, and the effect of blood transfusions.
    GRAHAM JB; BUCKWALTER JA
    J Exp Med; 1949 Aug; 90(2):97-111. PubMed ID: 18136192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.